World news wrapup: 30 April 2026
Canadian councillors scrutinise private opioid treatment; Auckland pharmacist ordered to pay damages to tenant; new US pharmacy union highlights organising at CVS London, Ontario: Councillors in the city of London …
April MIMS update
Some of the recent changes to the medicines landscape, with new products and indications New Products Fedratinib (as dihydrochloride monohydrate) (Inrebic) is an oral kinase inhibitor with activity against wild …
Catching ZZZs: raising awareness around sleep health
Sleep disorders are common, often undiagnosed and closely linked to chronic disease, placing community pharmacy in a prime position to identify risk and improve patient outcomes Key points Up to …
Nutrition in practice: how pharmacists are shaping their role
As the burden of lifestyle-related disease grows, the question may no longer be “should pharmacists engage in nutrition care”, but how the role can be sustainable, supported and defined Key …
The redemption of StrongRoom AI?
Has a pharmacy ‘white knight’ succeeded in restoring the reputation and finances of a tarnished former star? Angelo Pricolo believes they are on the way to doing so Who saved …
‘Heartbreaking’ case highlights need for support: Guild Insurance
The parents of a child who suffered a clonidine overdose due to a dispensing error are calling for legislative change to how some insurance funds are paid out The Adelaide …
Supplement brand fined over ad breach
Queensland-based company cops infringement notices totalling more than $79,000 over alleged unlawful advertising The Therapeutic Goods Administration (TGA) has issued four infringement notices to Switch Nutrition in relation to the alleged promotion of therapeutic …
Government-led promotion needed to boost 60-day uptake: study
Slower than forecast adoption of 60-day dispensing is being attributed to low uptake by GPs and resistance from pharmacists Changes to GP prescribing software, combined with clearer communication to patients …
PBAC go-ahead for adrenaline nasal spray
PBS listing recommendation for neffy, with PBAC citing previous shortages of adrenaline auto-injector pens The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of neffy nasal spray, for the …
Which opportunities should we be seizing?
A range of opportunities are now available for those seeking to expand or change their careers, and to enhance their business. But how do you choose which path to follow? …
Regulate infant formula marketing: AMA
Medical group calls for tighter controls over the promotion of infant formula, including in pharmacies The Australian Medical Association (AMA) wants retailers to be included in mandatory infant formula marketing …
The price ain’t right: Lilly
Positive funding recommendation for Mounjaro came with “unviable and unsustainable conditions”, sponsor says Eli Lilly is calling for “wholesale changes” to be made to the PBS (Pharmaceutical Benefits Scheme) after withdrawing its application …